Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Intervirology. 2009;52(1):29-34. doi: 10.1159/000212988. Epub 2009 Apr 17.

Echinacea purpurea polysaccharide reduces the latency rate in herpes simplex virus type-1 infections.

Author information

  • 1Faculty of Medicine, Golestan University of Medical Sciences and Health Care, Gorgan, Iran. ghaem_amir@yahoo.com

Abstract

OBJECTIVE:

During the latency period of herpes simplex virus type-1 (HSV-1), the virus can occasionally reactivate, travel back to the eye and cause recurrent ocular disease. As this condition arises from the ability of HSV-1 to produce a dormant infection, effective medication to prevent the virus enter a latent state should prevent it. In this study, we applied Echinacea polysaccharide (EP) fraction as prophylactic mediator for latency prevention.

METHODS:

In order to investigate the protective properties of EP, we evaluated its immunostimulatory functions on different immune aspects that play important roles in latency prevention (particularly IFN-gamma as one of the main indicators of cellular immunity and latency). Finally, we assessed establishment of latency by detection of thymidine kinase gene in trigeminal ganglia of BALB/c mice.

RESULTS:

We demonstrated that EP promotes immune response, leading to a reduced latency rate, and it has a promising effect on latency prevention.

CONCLUSION:

EP was able to exert an antiviral action on the development of recurrent HSV-1 disease when supplied prior to infection.

Copyright 2009 S. Karger AG, Basel.

PMID:
19372701
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk